Downscaling with an unstructured coastal-ocean model to the Goro Lagoon and the Po river delta branches

The Goro Lagoon Finite Element Model (GOLFEM) presented in this paper concentrates on the high-resolution downscaled model of the Goro Lagoon, along with five Po river branches and the coastal area of the Po delta in the northern Adriatic Sea (Italy) where crucial socio-economic activities take place. GOLFEM was validated by means of validation scores (bias – BIAS, root mean square error – RMSE, and mean absolute error – MAE) for the water level, current velocity, salinity and temperature measured at several fixed stations in the lagoon. The range of scores at the stations are: for temperature between −0.8 to +1.2◦C, for salinity from −0.2 to 5 PSU, for sea level 0.1 m. The lagoon is dominated by an estuarine vertical circulation due to a double opening at the lagoon mouth and sustained by multiple sources of freshwater inputs. The non-linear interactions among the tidal forcing, the wind and the freshwater inputs affect the lagoon circulation at both seasonal and daily time scales. The sensitivity of the circulation to the forcings was analyzed with several sensitivity experiments done with the exclusion of the tidal forcing and different configurations of the river connections. GOLFEM was designed to resolve the lagoon dynamics at high resolution in order to evaluate the potential effects on the clam farming of two proposed scenarios of human intervention on the morphology of the connection with the sea. We calculated the changes of the lagoon current speed and salinity, and using opportune fitness indexes related to the clams physiology, we quantified analytically the effects of the interventions in terms of extension and persistence of areas of the clams optimal growth. The results demonstrate that the correct management of this kind of fragile environment relies on both long-term (intervention scenarios) and short-term (coastal flooding forecasts and potential anoxic conditions) modeling, based on a flexible tool that is able to consider all the recorded human interventions on the river connections. This study also demonstrates the importance of designing a seamless chain of models that are capable of integrating local effects into the coarser operational oceanographic models

Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: Treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial

Background Neoangiogenesis is particularly abundant in small-cell lung cancer (SCLC) and is associated with poor prognosis. As a result of the promising nature of phase II studies, a randomized phase III trial was designed to assess the efficacy of adding bevacizumab to first-line chemotherapy with cisplatin-etoposide for treatment of extensive disease SCLC. We present the treatment rationale and study design of GOIRC trial (FARM6PMFJM study), a multicenter randomized phase III study, supported by AIFA (Agenzia Italiana del Farmaco). Patients and Methods Patients are randomized to receive either cisplatin 25 mg/m2 and etoposide 100 mg/m2 intravenously on days 1 to 3 (control arm) or the same chemotherapy combined with bevacizumab 7.5 mg/kg intravenously on day 1 (experimental arm). Treatment is repeated every 3 weeks and for a maximum of 6 courses. Patients randomized to the experimental arm in the absence of disease progression after 6 cycles continue bevacizumab alone until progression or for a maximum of 18 courses. Tumor assessment is done every 3 cycles. Major eligibility criteria are: age 65 18 years; histologically or cytologically documented extensive disease SCLC; Eastern Cooperative Oncology Group performance status 64 2; adequate hematological, hepatic and renal functions; no history of grade 2 or higher hemoptysis; and no evidence of tumor cavitation. The primary end point of this study is overall survival. Secondary end points include response rate, time to progression, and toxicity. Conclusion An interim futility analysis was performed by an Independent Data Monitoring Committee in September 2013 and the trial obtained approval to continue. As of July 31, 2014, 171 patients of 206 planned have been randomized

The Imaging X-Ray Polarimetry Explorer (IXPE): Pre-Launch

International audienceLaunched on 2021 December 9, the Imaging X-ray Polarimetry Explorer (IXPE) is a NASA Small Explorer Mission in collaboration with the Italian Space Agency (ASI). The mission will open a new window of investigation—imaging x-ray polarimetry. The observatory features three identical telescopes, each consisting of a mirror module assembly with a polarization-sensitive imaging x-ray detector at the focus. A coilable boom, deployed on orbit, provides the necessary 4-m focal length. The observatory utilizes a three-axis-stabilized spacecraft, which provides services such as power, attitude determination and control, commanding, and telemetry to the ground. During its 2-year baseline mission, IXPE will conduct precise polarimetry for samples of multiple categories of x-ray sources, with follow-on observations of selected targets